Retina Risk is a new app that patients can use to help screen for their risk of retinopathy.
The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.
Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
As 2018 signals the end of the patent cliff and branded generics face tougher competition from nonbranded manufacturers, companies are diversifying their portfolios and focusing on innovation to ensure long-term viability.
There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
The Agency Sees Potential in Generic Competition to Reduce Drug Costs for Patients With Diabetes
Pharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.
Pharmacists can use sound advice and practical foot care tips to help patients avert dangerous foot infections.
Sixty percent to 90% of patients with cancer with bone metastasis develop bone pain. In turn, bone pain can be the first sign that cancer has spread to the bone.
Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.
Medication therapy management has become an important buzzword in the world of pharmacy.
The December OTC Focus cases feature recalibrating a mercury-in-glass thermometer, a baby with a fever, and dosing for ibuprofen.
Although pharmacy schools are known for their advancements in pharmacy education, scientific discovery, and patient care, they still face an unspoken and universal truth shared among institutions of higher learning: students sometimes feel lost and unsure of themselves, and as if they have no one to whom they can turn.
Clinical trials are now evaluating the potential combination of PARP inhibitors with immunotherapy or other agents in patients with ovarian cancer.
These actions can eliminate vulnerabilities and ensure greater supply chain resiliency for the next pandemic—and beyond.
The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.
For more than a year now, the Pharmacy Leadership and Education Institute has enthusiastically contributed a number of articles to Pharmacy Times.
Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.
The treatment of epilepsy is complex and can cause drug-related problems and hamper quality of life. Clinical services performed by pharmacists may optimize the pharmacotherapy and avoid or mitigate these problems.
Approvals and indications of this drug were based on 3 main clinical trials.
Residencies are typically the first postgraduate experience pharmacy students ponder after pharmacy school.